BeyondSpring (BYSI) Net Cash Flow (2016 - 2026)
BeyondSpring's (BYSI) quarterly Net Cash Flow came in at -$3.9 million in Q2 2026, down 177.39% year-over-year from $5.0 million in Q2 2025, and down 30.32% quarter-over-quarter from -$3.0 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Net Cash Flow (2016 - 2026) Analysis & Trends
BeyondSpring has disclosed Net Cash Flow across 9 years of filings, most recently posting -$3.9 million for Q2 2026.
- In Q2 2026, Net Cash Flow fell 177.39% year-over-year to -$3.9 million; the TTM figure through Jun 2026 stood at -$17.9 million (down 222.06% YoY), while the FY2025 annual figure was -$4.0 million, down 140.36% from the prior year.
- Net Cash Flow came in at -$3.9 million for Q2 2026 at BeyondSpring, down from -$3.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $14.6 million in Q3 2024 to a low of -$8.7 million in Q4 2025.
- Average Net Cash Flow over 3 years is -$1.5 million, with a median of -$3.4 million recorded in 2026.
- Year-over-year, Net Cash Flow soared 171.24% in 2025 and slumped 240.31% in 2026.
- Over 3 years, Net Cash Flow stood at -$7.0 million in 2024, then fell by 24.18% to -$8.7 million in 2025, then jumped by 55.63% to -$3.9 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$3.9 million in Q2 2026, -$3.0 million in Q1 2026, and -$8.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 918.27 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 374.50 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 521.33 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 523.50 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | -3.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.85 Mn |
| Mar 31, 2026 | -2.96 Mn |
| Dec 31, 2025 | -8.68 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | -6.99 Mn |
| Sep 30, 2024 | 14.57 Mn |
| Jun 30, 2024 | -6.99 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2021 | -21.65 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | -39.14 Mn |
| Mar 31, 2021 | -19.03 Mn |
| Dec 31, 2020 | 78.91 Mn |
| Sep 30, 2020 | -6.99 Mn |
| Jun 30, 2020 | 13.16 Mn |
| Mar 31, 2020 | -11.05 Mn |
| Dec 31, 2019 | 11.27 Mn |
| Sep 30, 2019 | 23.91 Mn |